
|Articles|September 1, 2007
- Volume 0 0
WORLD HEALTH ORGANIZATION STUDIES TRAVEL RISKS
Author(s)Anna D. Garrett, PharmD, BCPS, CPP
Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.
Advertisement
In 2001, the World Health Organization (WHO) began a 2-phase project called the WHO Research Into Global Hazards ofTravel (WRIGHT) Project. The objectives of the project were toconfirm that the risk of venous thromboembolism (VTE) isincreased by air travel and to determine the magnitude of risk,the effect of other factors on the risk, and the effect of preventivemeasures on risk.
The key findings of the WRIGHT Phase I report include the following:
- The risk of VTE roughly doubles with flights greater than 4 hours and increaseswith longer flights or repeated flights within a short period of time.
- Overall, the absolute risk of VTE appears to be about 1 in 6000 healthy individuals,but the risk is primarily concentrated in patients with hypercoagulable conditions,those using birth control pills, or those who have other risk factors such asobesity, extremes of height (less than 5?2? or greater than 6?2?), older age, and cardiovasculardisease.
- The VTE risk is greatest immediately following a flight, but some risk persistsfor several weeks afterward.
Articles in this issue
about 19 years ago
Calming the Symptoms of Menopauseabout 19 years ago
Zoster Vaccineabout 19 years ago
pharmacy TECHNOLOGY productsabout 19 years ago
health-systems PRODUCT newsabout 19 years ago
can you READ these Rxs?about 19 years ago
can you READ these Rxs?about 19 years ago
Generic Times Product Newsabout 19 years ago
compounding HOTLINEabout 19 years ago
Human HRT Leads Compounding Renaissanceabout 19 years ago
Prescription-overdose Deaths Surpass Car-accident DeathsAdvertisement
Related to this article

Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.

Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.

A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.

Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.

Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.

Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.

Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
4
Ambulatory Pharmacists Convene in Boston at NEIAP's 2026 Annual Forum
5

